Cardiex Limited (CDX:ASX)
Cardiex Ltd, formerly AtCor Medical Holdings Ltd, is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company's clinical trial services, include study protocol assistance, study-specific user manual, operator training and certification, study-specific training materials, automated data transfer for expert over-read, quality assurance, ongoing data management, technical support and sponsor-defined data transfers. The Company also offers SphygmoCor technology, which is used in clinical trials for a range of therapeutic areas, including hypertension, renal disease, heart failure, inflammatory processes, diabetes and chronic obstructive pulmonary disease (COPD).